Avanos Medical Inc. (AVNS)
15.10
0.05 (0.33%)
At close: Mar 03, 2025, 3:59 PM
15.13
0.20%
After-hours: Mar 03, 2025, 04:55 PM EST
Avanos Medical Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 687.8M | 673.3M | 820M | 744.6M | 714.8M | 697.6M | 652.3M | 611.6M | 1.59B | 1.57B | 1.67B | 1.68B | 1.68B | 1.66B |
| Cost of Revenue | 306.5M | 293.6M | 370M | 380.3M | 341.5M | 295.4M | 261.4M | 274.7M | 1.03B | 1.04B | 1.12B | 1.07B | 1.08B | 1.07B |
| Gross Profit | 381.3M | 379.7M | 450M | 364.3M | 373.3M | 402.2M | 390.9M | 336.9M | 557.9M | 531.6M | 548.6M | 612.2M | 602.5M | 590.8M |
| Operating Income | -396.2M | 4.2M | 74M | 8.9M | -46.1M | -55.7M | 500K | -43.1M | 87.4M | -377.7M | 94.3M | 225.3M | 228M | 210.7M |
| Interest Income | 5.1M | 2.9M | 1.2M | 200K | 1.2M | 6.7M | 7.8M | 2.5M | 600K | 300K | 2.9M | 2.6M | 2.6M | 4.1M |
| Pretax Income | -403.3M | -7.9M | 65.2M | 5.8M | -60.5M | -64M | -18.1M | -72.2M | 55.3M | -410.5M | 91.2M | 227.8M | 229.8M | 214.6M |
| Net Income | -392.1M | -61.8M | 50.5M | 6.3M | -27.2M | -45.9M | 57.5M | 79.3M | 39.8M | -426.3M | 27.1M | 154.6M | 152.6M | 142.4M |
| Selling & General & Admin | 318.5M | 318.1M | 341.9M | 300.3M | 332.6M | 399.1M | 340.4M | 321.7M | 411.1M | 398.5M | 424.5M | 351.4M | 343M | 351.7M |
| Research & Development | 26.2M | 27.2M | 30.6M | 32.3M | 34.9M | 37.7M | 41.8M | 38.2M | 41.1M | 32.3M | 33.6M | 37.9M | 33M | 31.2M |
| Other Expenses | 432.8M | 30.2M | 3.5M | 22.8M | 51.9M | 21.1M | 8.2M | 20.1M | 18.3M | 4.5M | -3.8M | -2.4M | -1.5M | -2.8M |
| Operating Expenses | 777.5M | 375.5M | 376M | 355.4M | 419.4M | 457.9M | 390.4M | 380M | 470.5M | 435.3M | 454.3M | 386.9M | 374.5M | 380.1M |
| Interest Expense | 12.2M | 15M | 10M | 3.3M | 15.6M | 15M | 26.4M | 31.6M | 32.7M | 33.1M | 6M | 100K | 800K | 200K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 1.08B | 669.1M | 746M | 735.7M | 760.9M | 753.3M | 651.8M | 654.7M | 1.5B | 1.48B | 1.58B | 1.45B | 1.46B | 1.45B |
| Income Tax | -17M | 2M | 14.7M | 600K | -33.3M | -18.1M | -9.6M | -40.1M | 15.5M | 15.8M | 64.1M | 73.2M | 77.2M | 72.2M |
| Shares Outstanding (Basic) | 46M | 46.6M | 46.9M | 48.1M | 47.8M | 47.6M | 47.2M | 46.52M | 46.6M | 46.59M | 46.54M | 46.51M | 46.51M | 46.51M |
| Shares Outstanding (Diluted) | 46M | 46.6M | 47.3M | 48.6M | 47.8M | 47.6M | 47.2M | 46.8M | 47M | 46.59M | 46.54M | 46.51M | 46.51M | 46.51M |
| EPS (Basic) | -8.52 | -1.33 | 1.08 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | 3.06 |
| EPS (Diluted) | -8.52 | -1.33 | 1.07 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | 3.06 |
| EBITDA | -345.6M | 50.6M | 77.8M | 8.9M | -2M | -12.1M | 65.7M | -600K | -65.5M | -76.5M | 179.7M | 297.1M | 288.2M | 265.9M |
| Depreciation & Amortization | 45.5M | 46.1M | 41.1M | 38.3M | 42.9M | 36.9M | 33.5M | 40M | 41M | 65.4M | 85.4M | 69.2M | 57.6M | 51.1M |